Wendy Marder

ORCID: 0000-0001-7963-4206 · 2 papers in corpus

article 2012

Ovarian Damage during Chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility

·doi:10.4137/cmrh.s10415

Women with autoimmune diseases such as lupus, scleroderma, and vasculitis receiving cyclophosphamide for severe disease manifestations risk primary ovarian insufficiency(POI) due to gonadotoxicity of this therapy. In addition to loss of rep…

article 2005

Use of a gonadotropin‐releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

·doi:10.1002/art.21263

OBJECTIVE: Cyclophosphamide (CYC) therapy for systemic lupus erythematosus (SLE), a disease predominantly affecting women of childbearing age, causes an unacceptably high incidence of irreversible premature ovarian failure (POF). This study…